NDC product
Ferric Carboxymaltose
NDC 0781-3542 · Sandoz, Inc.
Key facts
| Product NDC | 0781-3542 |
|---|---|
| Proprietary name | Ferric Carboxymaltose |
| Nonproprietary name | Ferric Carboxymaltose Injection |
| Substances | FERRIC CARBOXYMALTOSE |
| Dosage form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Labeler | Sandoz, Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Application number | NDA203565 |
| Pharmacologic classes | Iron [CS], Parenteral Iron Replacement [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA] |
| Marketing start | Jul 3, 2026 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: